The SCN1A gene gives brain nerve cells instructions for a sodium channel that helps control electrical signaling. The protein made by this gene helps your cells pass signals in a steady, coordinated way. If a harmful variant reduces this channel’s function, seizures can happen more easily, often starting in infancy or early childhood, and some people also have learning, movement, or balance challenges. SCN1A is best known for its link to Dravet syndrome, a rare epilepsy condition.
What is a gene?
Genes are segments of DNA that give your cells information to make molecules or regulate processes in the body. Some genes hold the directions for making proteins, the parts of cells that do much of the work. Other genes mainly help determine when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
SCN1AGene function
What if the gene works
The SCN1A gene helps brain nerve cells control electrical signaling. Its protein forms part of a sodium channel that supports fast, well-timed messages, especially in cells that calm brain activity. This helps keep brain networks balanced.
Risk
What if the gene does not work
Variants in the SCN1A gene can cause an epilepsy spectrum, from milder febrile seizure syndromes to Dravet syndrome, often with developmental effects. Milder and more severe variants can influence when seizures begin and how broad the features are.
Treatment
What does that mean for your treatment
Pathogenic or loss-of-function variants in the SCN1A gene can change anti-seizure drug choices. Medicines that block sodium channels, such as carbamazepine, lamotrigine, phenytoin, and oxcarbazepine, may worsen seizures and are usually avoided. Care often centers on other options, including valproate, clobazam, stiripentol, cannabidiol, or fenfluramine, depending on the person’s seizure pattern and age.
Conditions associated with SCN1A
Gene function
What if the gene works
Your brain depends on quick, well timed electrical signals to think, move, and process sensation. The SCN1A gene helps nerve cells in the brain send electrical messages by making part of a sodium channel, a tiny gate in the cell membrane. These channels support smooth communication across brain circuits.
The SCN1A gene makes a key part of a sodium channel that opens for a split second during nerve activity. This lets sodium enter the cell and helps begin an electrical signal.
These channels sit in parts of nerve cells that launch and pass along signals. Their quick opening and closing helps the message travel with accurate timing.
Many SCN1A channels work in brain cells that help calm nearby nerve activity. By supporting these cells, the SCN1A gene helps keep brain signaling balanced and well timed.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SCN1A gene often change the Nav1.1 sodium channel so it opens and closes abnormally, works less well, or never reaches the nerve cell surface. In many people, how SCN1A gene variants affect sodium channels depends on the exact DNA change: milder variants may leave some channel activity, while more severe loss of function variants can sharply reduce it. This often tracks with a milder seizure pattern at one end and earlier, more severe epilepsy, including Dravet syndrome, at the other.
How variants are linked to conditions
Pathogenic variants in the SCN1A gene are best known for causing epilepsy conditions, especially Dravet syndrome and generalized epilepsy with febrile seizures plus (GEFS+). Some SCN1A variants can also lead to other developmental and epileptic encephalopathies, and a smaller number are linked to familial hemiplegic migraine. In families searching for how SCN1A variants are linked to conditions, the clearest connection is to seizure conditions, though the age of onset and severity can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For many living with an SCN1A change, the variant itself is the main driver of risk, especially for seizure conditions such as Dravet syndrome. Seizures can be more likely with fever, illness, overheating, flashing lights, or missed sleep. These steps do not remove the genetic risk, but avoiding known triggers can help lower the chance of seizures.
Inheritance of SCN1A variants
Most SCN1A-related conditions follow an autosomal dominant inheritance pattern, which means a child can inherit the variant from one affected parent. If a parent carries a disease-causing variant in the SCN1A gene, each child has a 50% chance of inheriting it. The SCN1A inheritance pattern also includes new, de novo variants, so some people have the condition even though neither parent carries the variant. A parent who does not carry the variant in their blood usually has a low chance of having another child with the same variant.
What does my SCN1A result mean for my family?
SCN1A-related conditions usually run in families in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same gene change. That can matter even when symptoms differ, because one family member may have severe seizures while another has milder epilepsy or fever-triggered seizures. Some SCN1A changes happen new in the child, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
SCN1A genetic testing for epilepsy uses a blood sample or cheek swab to read the gene and look for variants. Results may identify a pathogenic variant, show a harmless change, or find a variant of uncertain significance, which means its meaning is not yet clear.
When should I consider getting a genetic test?
SCN1A testing may help if a baby or child has repeated seizures, especially with fever, long seizures, or seizures starting in the first year of life. It can also be useful with a family history of epilepsy. A result may help explain a condition such as Dravet syndrome.
A genetic result is only one part of your health story
A genetic finding can provide valuable insight, but what it reveals depends on the condition and the type of variant involved. Lifestyle, environment, age, and medical history are among the many factors that shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment may work well for one person, have less effect in another, or cause more side effects in someone else. Differences in how the body absorbs, breaks down, transports, or responds to a drug are common, and they can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medicines. By looking at connections between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes influence both how strongly a drug works and how the body processes it. This understanding can support more informed and individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SCN1A gene
When should I seek medical advice?
There is not yet a broadly confirmed drug-response role for this gene, so general questions about medicines, side effects, or symptom changes are best discussed with your doctor. For the SCN1A gene, studies and clinical experience show that in some seizure conditions linked to SCN1A, certain anti-seizure medicines may make seizures worse, so prompt medical advice is important if seizures change after a medicine is started or adjusted.
History
SCN1A became a landmark gene in epilepsy research when variants in it were linked to generalized epilepsy with febrile seizures plus around 2000. Soon after, researchers found that many children with Dravet syndrome also carry a pathogenic SCN1A variant, which helped explain a condition that had long been recognized clinically but not genetically. Initially understood only through visible traits, later recognized as tied to a specific gene, this shift changed how many epilepsy syndromes were classified. From these first observations, research expanded steadily. Over time, SCN1A testing became part of routine genetic evaluation for early-onset seizure conditions and helped shape more precise diagnosis and family counseling.